303 results on '"Topaloglu O"'
Search Results
2. RWD16 Role of Real-World Evidence for Treatments Granted Access Under Cancer Drugs Fund: Lessons and Insights From Review of NICE Technology Assessment Reports (2019-2022)
3. EE68 Burden of Hospitalization, Costs and Co-Morbidities in Patients With Chronic Lymphocytic Leukemia: Analysis of Real-World Evidence Using National In-Patient Hospital Database
4. P47 Understanding Evidence Requirements for Diagnostic Devices for Reimbursement and Market Access: Insights and Lessons From Review of NICE Diagnostics Assessment Reports (2011-2022)
5. RWD79 Burden of Hospitalization, Costs and Comorbidities in Medicaid Patients With Veno-Occlusive Disease (VOD): Analysis of National In-Patient Hospital Database
6. HTA216 Assessment of Key Drivers of Economic Evaluations for Digital Health and Medical Technologies: Insights and Lessons From Review of NICE Medical Technology Assessment Reports (2010-2022)
7. HTA83 Role of Quality of Life in Health Technology Assessment Agency Final Recommendations: Insights and Lessons From Review of NICE Technology Assessment Reports (2019-2022)
8. CO48 Systematic Literature Review and Meta-Analysis of Endoscopic Improvement for Treatment of Moderate-Severe Ulcerative Colitis
9. EE613 Burden of Hospitalization, Costs and Co-Morbidities in Medicare Patients With Chronic Graft Versus Host Disease: Analysis of National In-Patient Hospital Database
10. EE605 Feasibility Assessment of Using MiToS Staging System for Conducting Health Economic Analysis in Amyotrophic Lateral Sclerosis (ALS)
11. CO11 Comparison of Relapse Rates in Ulcerative Colitis Patients With Mayo Endoscopic Score of 0 or 1: Systematic Literature Review and Meta-Analysis
12. CO119 Systematic Review and Meta-Analysis of Mucosal Healing Outcomes With Biologics in Treatment of Ulcerative Colitis and Crohn's Disease
13. HTA36 Value of Real-World Evidence for Treatments for Ultra Orphan or Rare Diseases: Lessons and Insights From Review of NICE Highly Specialized Technology Assessment Reports (2016-2022)
14. PB2335: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICAID PATIENTS WITH SICKLE CELL DISEASE (SCD): ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
15. PB2333: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICARE PATIENTS WITH CHRONIC GRAFT VERSUS HOST DISEASE: ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
16. PB2336: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICAID PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
17. PB2334: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
18. PB2337: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICAID PATIENTS WITH VENO-OCCLUSIVE DISEASE (VOD): ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
19. Obstructive sleep apnea syndrome and its association with vitamin D deficiency
20. Is there a Relationship between Serum IGF-1 and Thyroid Nodule, Thyroid or Ovarian Volume in Polycystic Ovarian Syndrome?
21. Assessment of left ventricular functions by tissue Doppler echocardiography in patients with Cushing’s disease
22. EE552 Importance of Half Cycle Correction for Cost-Effectiveness Analysis: Case Study of Sacubitril/Valsartan Vs in Enalapril Heart Failure with Reduced Ejection Fraction
23. RWD172 Incidence and Burden of Bronchiectasis in Patients with Primary Immunodeficiency (PI) Diseases
24. RWD170 Understanding Burden of Veno-Occlusive Disease (VOD): Comparison of Hospital Stays with Vod Principal Versus Secondary Diagnosis
25. RWD98 Understanding the Role of Real-World Evidence for Reimbursement and Market Access of Ultra Orphan Drugs: Insights and Lessons from Case Studies of NICE Highly Specialized Technology (HST) Assessment Reports
26. RWD113 Understanding Burden and Drivers of Long Hospital Length of Stay in Patients with Heart Failure with Reduced Ejection Fraction (HFREF)
27. RWD49 Burden of Hospitalizations in Amyotrophic Lateral Sclerosis (ALS): Comparison of Medicare and Private Payer Populations
28. RWD24 Veno-Occlusive Disease (VOD) Incidence and Treatment Trends Insights from Latest Systematic Review of Case Reports (2018-2023)
29. HTA44 Economic Modeling Insights for Ultra Orphan Drugs Based on Review of NICE Highly Specialized Technology (HST) Assessment Reports
30. HTA9 Evidence Generation Strategy and Insights for Rare Diseases: Case Studies of Mistakes Identified By NICE in Highly Specialized Technology (HST) Assessments
31. HPR64 Implications of Inflation Reduction Act (IRA) on Budget Impact and Cost-Effectiveness Modeling
32. EE200 Simple Approach for Developing Parametric Survival Based Cost-Effectiveness Analysis (CEA): Case Study of Heart Failure with Reduced Ejection Fraction (HFREF)
33. EE193 Burden of Severe Infections in Primary Immunodeficiency (PI) Diseases
34. EE87 Insights and Lessons from Systematic Literature Review of Budget Impact Model Methodologies for United States Payers
35. Effects of percutaneous laser ablation treatment in benign solitary thyroid nodules on nodule volume, thyroglobulin and anti-thyroglobulin levels, and cytopathology of nodule in 1 yr follow-up
36. Is There a Relationship between Serum IGF-1 and Thyroid Nodule, Thyroid or Ovarian Volume in Polycystic Ovarian Syndrome?
37. Quality of Life Outcomes in Treatments for Symptomatic Uterine Fibroids: A Systematic Literature Review
38. PCN56 BURDEN OF HOSPITALIZATIONS IN NON-HODGKIN’S LYMPHOMA WITH AND WITHOUT HEMATOPOIETIC STEM CELL TRANSPLANT: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
39. PRO27 HOSPITAL LENGTH OF STAY, COSTS AND COMORBIDITIES IN BETA-THALASSEMIA: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
40. PIN22 MORTALITY, MORBIDITY AND BURDEN OF HOSPITALIZATIONS IN INFLUENZA PATIENTS WITH LOW AND HIGH COMORBIDITY INDEX: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
41. PSU10 IMPACT OF BILE DUCT INJURY DURING CHOLECYSTECTOMY ON HOSPITAL LENGTH OF STAY AND COSTS: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
42. PCN141 COMPARISON OF BURDEN OF HOSPITALIZATIONS IN ACUTE MYELOID LEUKEMIA WITH AND WITHOUT HEMATOPOIETIC STEM CELL TRANSPLANT: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
43. PGI11 COMPARISON OF BURDEN OF HOSPITALIZATIONS IN INFLAMMATORY BOWEL DISEASE (IBD) WITH AND WITHOUT COLORECTAL CANCER: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
44. PCN20 OVERALL RESPONSE AND COMPLETE RESPONSE WITH ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) : A SYSTEMATIC REVIEW AND META-ANALYSIS
45. PUK12 BURDEN OF HOSPITALIZATIONS IN UTERINE FIBROIDS (UF) PATIENTS WITH LOW AND HIGH COMORBIDITY INDEX: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
46. ND2 BURDEN OF HOSPITALIZATIONS IN HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) WITH AND WITHOUT HEMATOPOIETIC STEM CELL TRANSPLANT: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
47. PGI12 COMPARISON OF BURDEN OF HOSPITALIZATIONS IN CROHN'S DISEASE AND ULCERATIVE COLITIS: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
48. PCN82 BURDEN OF HOSPITALIZATIONS IN MULTIPLE MYELOMA WITH AND WITHOUT HEMATOPOIETIC STEM CELL TRANSPLANT: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
49. PMH14 BURDEN OF HOSPITALIZATIONS IN NARCOLEPSY PATIENTS WITH LOW AND HIGH COMORBIDITY INDEX: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
50. PDB30 HOSPITALIZATIONS AND COMORBIDITIES IN CHRONIC GOUT WITH AND WITHOUT TOPHUS: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.